Sanofi, JDRF form promotional agreement
By Derek Winkler
Pharmaceutical company Sanofi-Aventis Canada and charitable organization the Juvenile Diabetes Research Foundation Canada have signed a promotional agreement. The two organizations will collaborate on activities intended to raise awareness of autoimmune type one diabetes and the importance of its early detection.
“At Sanofi, we believe diabetes education is a critical tool for individuals living with the condition and for the healthcare professionals who care for them,” said Ahmed Moussa, general manager of general medicines at Sanofi Canada. “At the core of our partnership with JDRF lies a shared commitment to shed light on the journey towards the onset of T1D. By illuminating the stages preceding clinical symptoms, we aim to equip individuals with the knowledge needed to make informed decisions about their health. Early detection can empower individuals to face an eventual diagnosis with the education and support to preemptively manage their condition.”